ES2173145T3 - Preparado de ranitidina desamargado. - Google Patents

Preparado de ranitidina desamargado.

Info

Publication number
ES2173145T3
ES2173145T3 ES95119604T ES95119604T ES2173145T3 ES 2173145 T3 ES2173145 T3 ES 2173145T3 ES 95119604 T ES95119604 T ES 95119604T ES 95119604 T ES95119604 T ES 95119604T ES 2173145 T3 ES2173145 T3 ES 2173145T3
Authority
ES
Spain
Prior art keywords
ranitidine
prepn
acid
dismarked
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95119604T
Other languages
English (en)
Inventor
Manfred Assmus
Hans-Ulrich Petereit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roehm GmbH Darmstadt
Original Assignee
Roehm GmbH Darmstadt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roehm GmbH Darmstadt filed Critical Roehm GmbH Darmstadt
Application granted granted Critical
Publication of ES2173145T3 publication Critical patent/ES2173145T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

RANITIDINA CON ACIDOS POLICARBOXILICOS, COMO COPOLIMEROS DE ACIDO ACRILICO Y/O METACRILICO CON SUS ESTERES D EALQUILO DE CADENA CORTA, SALES SOLUBLES EN AGUA CON SABOR AMARGO MUY REBAJADO. SON APROPIADOS COMO PREPARADOS LIQUIDOS CONTRA LA GASTRITIS.
ES95119604T 1994-12-17 1995-12-13 Preparado de ranitidina desamargado. Expired - Lifetime ES2173145T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE9420259U DE9420259U1 (de) 1994-12-17 1994-12-17 Entbittertes Ranitidin-Präparat

Publications (1)

Publication Number Publication Date
ES2173145T3 true ES2173145T3 (es) 2002-10-16

Family

ID=6917578

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95119604T Expired - Lifetime ES2173145T3 (es) 1994-12-17 1995-12-13 Preparado de ranitidina desamargado.

Country Status (6)

Country Link
US (1) US5708021A (es)
EP (1) EP0721785B1 (es)
JP (1) JPH08208468A (es)
AT (1) ATE214947T1 (es)
DE (2) DE9420259U1 (es)
ES (1) ES2173145T3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
WO2000010562A1 (fr) * 1998-08-18 2000-03-02 Leonidov Nikolai B Forme physiquement stable et amorphe aux rayons x de ranitidine d'hydrochlorure ayant une action anti-ulcere accrue, et procede de production
DE10133546A1 (de) * 2001-07-11 2003-03-06 Petra Bastian Mischkomplexe zur Maskierung bitter schmeckender Substanzen
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
BRPI0820770A2 (pt) * 2007-12-12 2015-06-16 Basf Se Sal solúvel em água polimérico de medicamentos, forma de administração sólida, e, método para produzir sais solúveis em água poliméricos de medicamentos.
JP5560701B2 (ja) * 2008-12-26 2014-07-30 ライオン株式会社 ラニチジン含有医薬固形製剤及びラニチジン担持粒子の製造方法
JP5609105B2 (ja) * 2009-12-24 2014-10-22 ライオン株式会社 ラニチジン含有被覆粒子及びその製造方法
JP2013536884A (ja) 2010-08-31 2013-09-26 ビーエーエスエフ ソシエタス・ヨーロピア クエン酸に基づいた分枝ポリエステル、さらにはそれらの製造及び使用
EP3337458B1 (de) 2015-08-21 2019-10-16 Basf Se Verwendung von wasserlöslichen polymeren auf basis von n-vinylpyrrolidon und acrylsäure als pharmazeutische hilfstoffe
US10610487B2 (en) 2015-08-21 2020-04-07 Basf Se Salts of active ingredients with polymeric counterions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629392A (en) * 1969-08-15 1971-12-21 Gilbert S Banker Entrapment compositions and processes
US4539199A (en) * 1981-01-14 1985-09-03 Egyt Gyogyszervegyeszeti Gyar Sustained release pharmaceutical compositions
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
CH664284A5 (en) * 1985-07-08 1988-02-29 Arcopharma Sa Chloroquine medicaments without bitter taste - contain complex of chloroquine with copolymer of methacrylic] acid and methyl methacrylate]
HU201683B (en) * 1987-08-04 1990-12-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for promoting healing of wounds
US5219563A (en) * 1988-05-11 1993-06-15 Glaxo Group Limited Drug adsorbates
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9211148D0 (en) * 1992-05-26 1992-07-08 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
JPH08208468A (ja) 1996-08-13
DE9420259U1 (de) 1995-02-09
EP0721785A2 (de) 1996-07-17
ATE214947T1 (de) 2002-04-15
EP0721785B1 (de) 2002-03-27
DE59510127D1 (de) 2002-05-02
US5708021A (en) 1998-01-13
EP0721785A3 (de) 1997-08-06

Similar Documents

Publication Publication Date Title
ES2173145T3 (es) Preparado de ranitidina desamargado.
ATE247478T1 (de) Bioartifizielle vorrichtungen und hierfür verwendete zellhaltige matrix
FR2692076B1 (fr) Element d'accumulateur base sur le principe de la circulation de l'oxygene.
ATE258196T1 (de) Vernetzte acrylat copolymere in wässrige emulsion mit verdickungs und suspensionseigenschaften
DE69535737D1 (de) Pflaster zur externen anwendung
GB9124487D0 (en) The use of biomaterials for tissue repair
DE3777808D1 (de) Polysiloxane mit ueber sic-gruppen gebundenen (meth)acrylsaeureestergruppen und deren verwendung als strahlenhaertbare beschichtungsmittel fuer flaechige traeger.
CA2183098A1 (fr) Composition cosmetique a pouvoir fixant et/ou conditionneur contenant un copolymere acrylique particulier
ATE130187T1 (de) Amphotere zusammensetzungen und polymerformen von alpha-hydroxy-säuren, und ihre therapeutische anwendung.
FI962111A0 (fi) Mikrokapseloidut 3-piperidinyyli-substituoidut 1,2-bentsisoksatsolit ja 1,2-bentsisotiatsolit
ES2100219T3 (es) Nuevos polimeros absorbentes, su procedimiento de preparacion y su aplicacion.
TR199701212T1 (xx) �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�.
NO954188D0 (no) Modifisert-protein- og -peptid - farmasöytika
DK0670736T3 (da) Mærket interleukin-8 og medicinske anvendelser deraf
DE59406374D1 (de) Hydroxamsäuren und hydroxamsäureether sowie ihre verwendung als komplexbildner
ATE196427T1 (de) Zusammensetzung mit verbesserter wasserlöslichkeit, enthaltend eine wasserunlösliche oder an wasser schwerunlösliche verbindung
FR2799366B1 (fr) Composition sous forme d'emulsion huile-dans-eau contenant des fibres, et ses utilisations notamment cosmetiques
ES2099272T3 (es) Composiciones oftalmicas a base de oxicam o de derivados de oxicam.
WO1996005845A3 (en) Treatment of disease and conditions associated with macrophage infiltration in particular stroke and myocardial infarction
DK0391274T3 (da) Hudbeskyttelsespræparat
ATE63684T1 (de) Deodorant.
ATE190498T1 (de) Stabile, pharmazeutische zusammensetzungen die hybrid alpha-interferon enthalten
RS49520B (sr) Antimikrobno aktivne smeše
DE3872849D1 (de) Alles enthaltende zusammensetzung fuer die behandlung von kesselwasser.
DE60100021D1 (de) Kosmetische oder pharmazeutische Zusammensetzung enthaltend ein Ester des Dextrins und ein hydrophiles Geliermittel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 721785

Country of ref document: ES